Using Cognitive Behavioral Therapy for Insomnia in People with Type 2 Diabetes, Pilot RCT Part I: Sleep and Concomitant Symptom.

OBJECTIVE/BACKGROUND: The primary aim of this study was to examine the effect of Cognitive Behavioral Therapy for Insomnia (CBT-I) on the severity of insomnia in people with Type 2 diabetes (T2D) compared to a health education (HE) control group. The secondary aim was to explore the effect of CBT-I on other sleep outcomes and concomitant symptoms.

PARTICIPANTS

Twenty-eight participants with T2D were randomly assigned to CBT-I ( = 14) or HE ( = 14).

METHODS

Validated assessments were used at baseline and post intervention to assess sleep outcomes and concomitant symptoms. In addition, actigraph and sleep diaries were used to measure sleep parameters. Independent sample tests and Mann-Whitney tests were utilized to measure between-group differences in the mean change scores.

RESULTS

Participants in the CBT-I group showed higher improvements in the following mean change scores compared to the HE group: insomnia symptoms ( = 1.78; < .001), sleep quality ( = 1.53; =.001), sleep self-efficacy ( = 1.67; < .001). Both actigraph and sleep diary showed improvements in sleep latency and sleep efficiency in the CBT-I group as compared to the HE group. In addition, participants in the CBT-I group showed greater improvement in the mean change scores of depression symptoms ( = 1.49; = .002) and anxiety symptoms ( = 0.88; = .04) compared to the HE group.

CONCLUSION

This study identified a clinically meaningful effect of CBT-I on sleep outcomes and concomitant symptoms in people with T2D and insomnia symptoms. Further work is needed to investigate the long-term effects of CBT-I in people with T2D and insomnia symptoms.